Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin

Breast cancers can be divided into several types. Because triple-negative breast cancer (TNBC) is the most refractory to current anti-cancer therapies, efficient treatment has been urgently required. Members of the Bcl-2 family play pro- and anti-apoptotic roles in mitochondria-mediated apoptosis. S...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Inao, Touko, Iida, Yuichi, Moritani, Tamami, Okimoto, Tamio, Tanino, Ryosuke, Kotani, Hitoshi, Harada, Mamoru
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5986635/
https://ncbi.nlm.nih.gov/pubmed/29876007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25370
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares